R Montal1, M Oliva2, M Taberna2,3, L De Avila4, A Rovira5, M Cos6, M Mañós3,5, V Navarro7, J Nogués5, A Lozano8, L Rodríguez9, E Vilajosana2, S Vázquez2, R Mesia2,3. 1. Medical Oncology Department, Institut Català Oncologia, Avinguda de la Granvia de l'Hospitalet, 199-203, 08908, Hospitalet de Llobregat, Spain. rmontal@iconcologia.net. 2. Medical Oncology Department, Institut Català Oncologia, Avinguda de la Granvia de l'Hospitalet, 199-203, 08908, Hospitalet de Llobregat, Spain. 3. University of Barcelona, Barcelona, Spain. 4. Medical Oncology Department, Instituto Oncológico del Hospital Provincial de Castellón, Castellón de la Plana, Spain. 5. Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain. 6. Radiology Department, Institut de Diagnòstic per la Imatge, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain. 7. Clinical Investigation Unit, Institut Català Oncologia, Hospitalet de Llobregat, Spain. 8. Radiation Oncology Department, Institut Català Oncologia, Hospitalet de Llobregat, Spain. 9. PET Unit, Institut de Diagnòstic per la Imatge, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain.
Abstract
PURPOSE: Management of residual neck disease (RND) is one of the unsolved points after bio-radiotherapy (BRT) in loco-regional advanced squamous-cell carcinoma of the head and neck (SCCHN). The aims of the study were to characterize the radiological pattern of response by computed tomography (CT) and to assess the role of positron-emission tomography (PET)/CT in this setting for a better decision-making in the indication of neck dissection (ND). METHODS: We retrospectively reviewed 202 patients consecutively diagnosed with node-positive SCCHN (N1: 24; N2: 152; N3: 26) who had been treated with concomitant radiotherapy and cetuximab with or without previous induction chemotherapy between 2006 and 2013. Radiological evaluation after treatment was assessed by standard criteria using CT and in addition by PET/CT when RND was suspected in cases from 2010. RESULTS: There were 42 (21 %) patients who achieved complete response of the primary tumor persisting RND by CT. From this group, 24 patients were managed without PET/CT, leading to the performance of ND in 22 (92 %). On the other hand, 18 patients underwent PET/CT and ND was performed in only 6 (33 %). The overall survival was not different between both groups (p = 0.32). After histological examination and follow-up, PET/CT obtained a positive predictive value of 56 % and a negative predictive value of 89 %. CONCLUSIONS: Radiological response after BRT is similar to that after treatment with chemo-radiotherapy, thereby validating in this scenario the accepted CT criteria to define complete response of the neck. However, when RND is suspected by CT, PET/CT is useful to prevent unnecessary ND.
PURPOSE: Management of residual neck disease (RND) is one of the unsolved points after bio-radiotherapy (BRT) in loco-regional advanced squamous-cell carcinoma of the head and neck (SCCHN). The aims of the study were to characterize the radiological pattern of response by computed tomography (CT) and to assess the role of positron-emission tomography (PET)/CT in this setting for a better decision-making in the indication of neck dissection (ND). METHODS: We retrospectively reviewed 202 patients consecutively diagnosed with node-positive SCCHN (N1: 24; N2: 152; N3: 26) who had been treated with concomitant radiotherapy and cetuximab with or without previous induction chemotherapy between 2006 and 2013. Radiological evaluation after treatment was assessed by standard criteria using CT and in addition by PET/CT when RND was suspected in cases from 2010. RESULTS: There were 42 (21 %) patients who achieved complete response of the primary tumor persisting RND by CT. From this group, 24 patients were managed without PET/CT, leading to the performance of ND in 22 (92 %). On the other hand, 18 patients underwent PET/CT and ND was performed in only 6 (33 %). The overall survival was not different between both groups (p = 0.32). After histological examination and follow-up, PET/CT obtained a positive predictive value of 56 % and a negative predictive value of 89 %. CONCLUSIONS: Radiological response after BRT is similar to that after treatment with chemo-radiotherapy, thereby validating in this scenario the accepted CT criteria to define complete response of the neck. However, when RND is suspected by CT, PET/CT is useful to prevent unnecessary ND.
Entities:
Keywords:
Bio-radiotherapy; Cetuximab; Neck dissection; PET/CT; Residual neck disease; Squamous-cell carcinoma of the head and neck
Authors: Sandro V Porceddu; David I Pryor; Elizabeth Burmeister; Bryan H Burmeister; Michael G Poulsen; Matthew C Foote; Benedict Panizza; Scott Coman; David McFarlane; William Coman Journal: Head Neck Date: 2011-01-14 Impact factor: 3.147
Authors: Anuj Goenka; Luc G T Morris; Shyam S Rao; Suzanne L Wolden; Richard J Wong; Dennis H Kraus; Nisha Ohri; Jeremy Setton; Benjamin H Lok; Nadeem Riaz; Borys R Mychalczak; Heiko Schoder; Ian Ganly; Jatin P Shah; David G Pfister; Michael J Zelefsky; Nancy Y Lee Journal: Int J Cancer Date: 2013-03-29 Impact factor: 7.396
Authors: Ann Tan; David J Adelstein; Lisa A Rybicki; Jerrold P Saxton; Ramon M Esclamado; Benjamin G Wood; Robert R Lorenz; Marshall Strome; Marjorie A Carroll Journal: Arch Otolaryngol Head Neck Surg Date: 2007-05
Authors: Arlene A Forastiere; Qiang Zhang; Randal S Weber; Moshe H Maor; Helmuth Goepfert; Thomas F Pajak; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Wade Thorstad; Henry Wagner; John F Ensley; Jay S Cooper Journal: J Clin Oncol Date: 2012-11-26 Impact factor: 44.544